Literature DB >> 16333095

Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Ralf René Reinert1, Michael R Jacobs, Peter C Appelbaum, Saralee Bajaksouzian, Soraia Cordeiro, Mark van der Linden, Adnan Al-Lahham.   

Abstract

High-level penicillin G-resistant as well as multidrug-resistant Streptococcus pneumoniae isolates were first described in South Africa in 1977. The relationship between these original multidrug-resistant South African isolates and other resistant clones was investigated. Twenty-six representative isolates isolated from initial outbreaks in South Africa from 1977 to 1978 were characterized by multilocus sequence typing and pulsed-field gel electrophoresis. Twenty-one isolates were penicillin resistant and five were penicillin intermediate, with variable susceptibilities to macrolides, clindamycin, chloramphenicol, tetracycline, and trimethoprim-sulfamethoxazole. Fourteen isolates were serotype 19A, 11 were serotype 6A, and one was serotype 14. Penicillin-resistant serotype 19A isolates belonged to three closely related sequence types (STs), ST 41 (n = 6), ST 1605 (n = 3), and ST 1656 (n = 1). Penicillin-resistant serotype 6A isolates belonged to two closely related STs, ST 1094 (n = 10) and ST 1607 (n = 1), and were not closely related to other international clones. The serotype 14 penicillin-intermediate isolate was not closely related to the other isolates from South Africa but was a predicted founder of a clonal group with 41 different STs. Five new STs, ST 1605, ST 1607, ST 1608, ST 1610, and ST 1656, are described for the first time in this study. New molecular methods have characterized the original multiply resistant South African pneumococcal isolates from 1977 to 1978 and have shown the relationships of these clones to major pneumococcal clones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333095      PMCID: PMC1317191          DOI: 10.1128/JCM.43.12.6035-6041.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Resistance phenotypes and multi-drug resistance in Streptococcus pneumoniae (PROTEKT years 1-3 [1999-20021).

Authors:  R R Reinert
Journal:  J Chemother       Date:  2004-12       Impact factor: 1.714

2.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Three predominant clones identified within penicillin-resistant South African isolates of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

4.  Studies on induced resistance to penicillin in a pneumococcus type I.

Authors:  K R ERIKSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1945

5.  Susceptibility of pneumococci to nine antibiotics.

Authors:  J W Kislak; L M Razavi; A K Daly; M Finland
Journal:  Am J Med Sci       Date:  1965-09       Impact factor: 2.378

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Optochin revisited: defining the optimal type of blood agar for presumptive identification of Streptococcus pneumoniae.

Authors:  M A Gardam; M A Miller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

Review 8.  Clinical efficacy of ketolides in the treatment of respiratory tract infections.

Authors:  Ralf René Reinert
Journal:  J Antimicrob Chemother       Date:  2004-04-29       Impact factor: 5.790

9.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

10.  Streptococcus pneumoniae resistant to penicillin and chloramphenicol.

Authors:  P C Appelbaum; A Bhamjee; J N Scragg; A F Hallett; A J Bowen; R C Cooper
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

View more
  7 in total

1.  Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.

Authors:  Adnan Al-Lahham; Peter C Appelbaum; Mark van der Linden; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

Review 2.  Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.

Authors:  Ana Maria Rivera; Helen W Boucher
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

Review 3.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience.

Authors:  Michael R Jacobs; Caryn E Good; Bernard Beall; Saralee Bajaksouzian; Anne R Windau; Cynthia G Whitney
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

5.  Molecular characterization of pneumococcal isolates from pets and laboratory animals.

Authors:  Mark van der Linden; Adnan Al-Lahham; Werner Nicklas; Ralf René Reinert
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

Review 6.  Population mobility, globalization, and antimicrobial drug resistance.

Authors:  Douglas W MacPherson; Brian D Gushulak; William B Baine; Shukal Bala; Paul O Gubbins; Paul Holtom; Marisel Segarra-Newnham
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

7.  The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success.

Authors:  Kelly L Wyres; Lotte M Lambertsen; Nicholas J Croucher; Lesley McGee; Anne von Gottberg; Josefina Liñares; Michael R Jacobs; Karl G Kristinsson; Bernard W Beall; Keith P Klugman; Julian Parkhill; Regine Hakenbeck; Stephen D Bentley; Angela B Brueggemann
Journal:  Genome Biol       Date:  2012-11-16       Impact factor: 13.583

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.